Interferon-β treatment reverses the detrimental effect of B-cell depletion therapy on respiratory virus infection
J Immunol. 2025 May 7:vkaf085. doi: 10.1093/jimmun/vkaf085. Online ahead of print. ABSTRACT Disease-modifying therapies (DMTs) are critical for managing autoimmunity such as multiple sclerosis (MS), yet concerns exist regarding their impact on viral infections. B-cell depletion (α-CD20) and IFN-β are 2 DMTs with seemingly opposing effects on viral infections. Pre-vaccine COVID-19 data linked B-cell depletion … Read more